Association of inflammatory cytokines with mortality in peritoneal dialysis patients

Yao‐Lung Liu, Jiung-Hsiun Liu, I‐Kuan Wang, Shu-Woei Ju, Tung‐Min Yu, I−Ru Chen, Yu‐Ching Liu, Chung‐Ming Huang, Shih‐Yi Lin, Chiz‐Tzung Chang,

Biomedicine · 2017 · 24 citations · 36 references

DOIFull text

Open access

Concepts

Abstract

AIMS: Previous study on association between pro-inflammatory cytokines and mortality in PD population is limited. We aimed to investigate here. METHODS: Total 50 patients who underwent incident PD were enrolled in this study. We measured the titers of pro-inflammatory cytokines Interleukin-18(IL-18), Interleukin-6 (IL-6), and Interleukin-1ß (IL-1ß). Study outcomes were all-cause mortality, cardiovascular-related mortality, and infection-caused mortality. Cox-regression model was used. RESULTS: year of PD. Increasing numbers of these risk markers of mortality was associated with decreasing survival advantages (P = 0.001). CONCLUSION: Age ≥ 50 years-old, diabetes, and inflammatory cytokines profiles at the start of PD therapy could predict for 7-year mortality in PD population.

References

36